This study is testing a new COVID-19 vaccine called GEO-CM04S1 against standard mRNA vaccines in people with blood cancers who have received a stem cell transplant or cellular therapy. The goal is to see if the new vaccine creates a stronger immune response in these vulnerable pa…
Phase: PHASE2 • Sponsor: GeoVax, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:28 UTC